Astera Labs, Inc. ALAB Cash & Equivalents
Cash & Equivalents at other companies
Other financials
Where this comes from
Reported directly by Astera Labs, Inc. in its filing.
Tagged under the XBRL concept us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents.
The official record: Astera Labs, Inc.’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about Astera Labs, Inc.'s cash & equivalents.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Astera Labs, Inc.'s cash & equivalents?
- Astera Labs, Inc. (ALAB) reported cash & equivalents of $148.36M in Q1 2026.
- How has Astera Labs, Inc.'s cash & equivalents changed year-over-year?
- Astera Labs, Inc.'s cash & equivalents increased by 70.5% year-over-year, from $86.99M to $148.36M.
- What is the long-term trend for Astera Labs, Inc.'s cash & equivalents?
- Over 3 years (2022 to 2025), Astera Labs, Inc.'s cash & equivalents has grown at a 30.1% compound annual growth rate (CAGR), from $76.09M to $167.68M.
- What does cash & equivalents mean?
- Cash on hand plus highly liquid investments with maturities of three months or less at purchase — treasury bills, money market funds, and commercial paper.